cholee65's Comments cholee65's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.com/user/1209771/comments What If Research In Nokia Existed? http://seekingalpha.com/article/1089691/comments?source=feed#comment-13208591 13208591 Wed, 02 Jan 2013 03:53:19 -0500 RIM's Rise Likely For Takeover Talk And Not BB10 http://seekingalpha.com/article/1070601/comments?source=feed#comment-12803441 12803441 Thu, 20 Dec 2012 00:09:12 -0500 Research In Motion Is Up Over 100%: Time To Sell? http://seekingalpha.com/article/1066981/comments?source=feed#comment-12676181 12676181 Mon, 17 Dec 2012 07:37:38 -0500 Research In Motion Is Up Over 100%: Time To Sell? http://seekingalpha.com/article/1066981/comments?source=feed#comment-12675571 12675571 Mon, 17 Dec 2012 07:17:48 -0500 Equity Offering Results In Price Weakness And A Buying Opportunity In A.P. Pharma http://seekingalpha.com/article/757731/comments?source=feed#comment-7895941 7895941 Sun, 29 Jul 2012 14:51:42 -0400 Small-Cap Adjuvants For Cancer Treatment http://seekingalpha.com/article/759311/comments?source=feed#comment-7895931 7895931 Sun, 29 Jul 2012 14:51:05 -0400 Gold Juniors Ready To Explode? http://seekingalpha.com/article/480651/comments?source=feed#comment-4198271 4198271 If you pick up 100,000 shares and it goes back to 50 cents; you'd make $37k.. That's what I am aiming for. ]]> Fri, 06 Apr 2012 04:51:23 -0400 If you pick up 100,000 shares and it goes back to 50 cents; you'd make $37k.. That's what I am aiming for. ]]> Cell Therapeutics Has Huge Potential To Double Or Triple Soon http://seekingalpha.com/article/414671/comments?source=feed#comment-3233831 3233831 http://bit.ly/xrPxih]]> Tue, 06 Mar 2012 20:25:24 -0500 http://bit.ly/xrPxih]]> The Case For A Lilly Takeover http://seekingalpha.com/article/411801/comments?source=feed#comment-3210161 3210161 http://bit.ly/xrPxih]]> Tue, 06 Mar 2012 08:32:25 -0500 http://bit.ly/xrPxih]]> The Case For A Lilly Takeover http://seekingalpha.com/article/411801/comments?source=feed#comment-3210141 3210141 http://bit.ly/xrPxih]]> Tue, 06 Mar 2012 08:32:10 -0500 http://bit.ly/xrPxih]]> Hedge Fund Tracking: Seth Klarman, Mohnish Pabrai And Meryl Witmer http://seekingalpha.com/article/368081/comments?source=feed#comment-3209971 3209971 http://bit.ly/xrPxih]]> Tue, 06 Mar 2012 08:27:10 -0500 http://bit.ly/xrPxih]]> 5 Large-Cap Healthcare Stocks Undervalued By EPS Trends http://seekingalpha.com/article/413071/comments?source=feed#comment-3209781 3209781 http://bit.ly/xrPxih]]> Tue, 06 Mar 2012 08:23:00 -0500 http://bit.ly/xrPxih]]> Varian Medical Systems: Fighting The Global Cancer Burden http://seekingalpha.com/article/411141/comments?source=feed#comment-3180201 3180201 http://bit.ly/xrPxih]]> Mon, 05 Mar 2012 09:55:14 -0500 http://bit.ly/xrPxih]]> Varian Medical Systems: Fighting The Global Cancer Burden http://seekingalpha.com/article/411141/comments?source=feed#comment-3180001 3180001 http://bit.ly/xrPxih]]> Mon, 05 Mar 2012 09:53:04 -0500 http://bit.ly/xrPxih]]> Analyzing Friday's Noteworthy Insider Buys And Sells In The Healthcare Sector http://seekingalpha.com/article/392251/comments?source=feed#comment-3087361 3087361 Watch this video on Oncovista; CEO’s last start-up Ilex Oncology, Genzyme bought for a billion dollars. Ilex got two cancer drugs approved faster than any biotech in 2 and 4 years via accelerated approval with FDA. I think OVIT could be a $100+ market cap company valued at $3-4 dollars in 18 months.. http://bit.ly/xrPxih]]> Thu, 01 Mar 2012 23:19:14 -0500 Watch this video on Oncovista; CEO’s last start-up Ilex Oncology, Genzyme bought for a billion dollars. Ilex got two cancer drugs approved faster than any biotech in 2 and 4 years via accelerated approval with FDA. I think OVIT could be a $100+ market cap company valued at $3-4 dollars in 18 months.. http://bit.ly/xrPxih]]> Lpath Dip May Be Simply A Buying Opportunity http://seekingalpha.com/article/403281/comments?source=feed#comment-3082081 3082081 http://bit.ly/xrPxih]]> Thu, 01 Mar 2012 18:58:56 -0500 http://bit.ly/xrPxih]]> Recent FDA Approval Makes Vertex A Ripe Target For Takeover http://seekingalpha.com/article/404691/comments?source=feed#comment-3077771 3077771 http://bit.ly/xrPxih]]> Thu, 01 Mar 2012 17:03:57 -0500 http://bit.ly/xrPxih]]> These Healthcare Companies Have Major March Catalysts http://seekingalpha.com/article/403491/comments?source=feed#comment-3075891 3075891 http://bit.ly/xrPxih]]> Thu, 01 Mar 2012 16:21:57 -0500 http://bit.ly/xrPxih]]> Prolor Biotech Is Poised For Growth http://seekingalpha.com/article/405071/comments?source=feed#comment-3075671 3075671 http://bit.ly/xrPxih]]> Thu, 01 Mar 2012 16:15:45 -0500 http://bit.ly/xrPxih]]> 4 Outperforming Biotech Stocks with Bullish Short Trends http://seekingalpha.com/article/402061/comments?source=feed#comment-3051661 3051661 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:46:22 -0500 http://bit.ly/xrPxih]]> 2 Speculative Biotechs To Consider http://seekingalpha.com/article/398721/comments?source=feed#comment-3051631 3051631 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:45:09 -0500 http://bit.ly/xrPxih]]> Alere (ALR +7.5%) jumps after beating Q4 estimates earlier today, as losses narrowed on sharply smaller write-downs related to its health-management business. http://seekingalpha.com/currents/post/135011?source=feed#comment-3051621 3051621 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:44:01 -0500 http://bit.ly/xrPxih]]> As Amgen Surges, Bristol Hunts For Takeover Targets http://seekingalpha.com/article/398361/comments?source=feed#comment-3051511 3051511 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:40:22 -0500 http://bit.ly/xrPxih]]> Biotech Stocks To Consider Going Into Earnings http://seekingalpha.com/article/402211/comments?source=feed#comment-3051461 3051461 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:38:33 -0500 http://bit.ly/xrPxih]]> Repros Therapeutics (RPRX) says the FDA has granted a meeting with the company to discuss the design of its Phase 3 studies for Androxal, as well as the components of the overall drug development program required for NDA submission. Shares +2.3% AH. http://seekingalpha.com/currents/post/171421?source=feed#comment-3051401 3051401 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:36:15 -0500 http://bit.ly/xrPxih]]> Vivus: Another Potentially Safe Short Play On Likely Drug Rejection http://seekingalpha.com/article/395871/comments?source=feed#comment-3051121 3051121 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:26:16 -0500 http://bit.ly/xrPxih]]> Biotech Focused Hedge Fund RA Capital's Top Q3 Picks http://seekingalpha.com/article/309107/comments?source=feed#comment-3050991 3050991 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 22:21:28 -0500 http://bit.ly/xrPxih]]> Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug http://seekingalpha.com/article/400351/comments?source=feed#comment-3044901 3044901 http://bit.ly/xrPxih]]> Wed, 29 Feb 2012 17:24:23 -0500 http://bit.ly/xrPxih]]> IPO Preview: Argos Therapeutics http://seekingalpha.com/article/399811/comments?source=feed#comment-3033531 3033531 Wed, 29 Feb 2012 12:28:59 -0500 Threshold Pharmaceuticals: Understanding The Recent Data http://seekingalpha.com/article/400491/comments?source=feed#comment-3023741 3023741 http://bit.ly/xrPxih where the CEO's last company Genzyme bought for $1 billion. THLD should be part of a basket of 20 long medical ideas in the sector. Buy on the dips. Some ideas: ASTX, SPPI, OVIT, GALE, THLD IVD and SURG. Plus I'd keep a close eye for Press Releases on Puma Biotechnology; from the makers of Cougar Biotechnology.]]> Wed, 29 Feb 2012 08:23:51 -0500 http://bit.ly/xrPxih where the CEO's last company Genzyme bought for $1 billion. THLD should be part of a basket of 20 long medical ideas in the sector. Buy on the dips. Some ideas: ASTX, SPPI, OVIT, GALE, THLD IVD and SURG. Plus I'd keep a close eye for Press Releases on Puma Biotechnology; from the makers of Cougar Biotechnology.]]>